This study investigates the treatment of locally advanced pancreatic cancer and local recurrence after surgery. It evaluates the effects of combining an investigational medication with chemotherapy and radiotherapy.
The purpose of this study is to assess the safety and effectiveness of the treatment combination. It focuses on understanding how well the treatment works and its safety profile.
- Who can participate: Adults aged 18 to 75 with locally advanced pancreatic cancer or local recurrence after surgery may participate. Participants must have a measurable lesion and meet specific health criteria.
- Study details: Participants will receive an investigational medication combined with chemotherapy and radiotherapy.